State Street’s Abiomed Inc ABMD Stock Holding History

State Street’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,071,180	Closed	-$509M	–	4930
2022 Q3	$509M	Sell	2,071,180 -15,590	-0.7%	-$4.21M	0.03%	460
2022 Q2	$516M	Buy	2,086,770 +70,134	+3%	+$18.9M	0.03%	474
2022 Q1	$668M	Sell	2,016,636 -12,602	-0.6%	-$3.88M	0.03%	446
2021 Q4	$729M	Buy	2,029,238 +46,309	+2%	+$15.6M	0.03%	448
2021 Q3	$645M	Buy	1,982,929 +27,736	+1%	+$9.4M	0.03%	461
2021 Q2	$610M	Buy	1,955,193 +56,338	+3%	+$17.3M	0.03%	475
2021 Q1	$605M	Sell	1,898,855 -49,853	-3%	-$16M	0.03%	446
2020 Q4	$632M	Sell	1,948,708 -71	-0%	-$19.6K	0.04%	418
2020 Q3	$540M	Sell	1,948,779 -36,566	-2%	-$10.5M	0.04%	411
2020 Q2	$480M	Sell	1,985,345 -10,454	-0.5%	-$2.1M	0.03%	431
2020 Q1	$290M	Sell	1,995,799 -63,598	-3%	-$10.6M	0.03%	509
2019 Q4	$351M	Buy	2,059,397 +78,159	+4%	+$14.5M	0.02%	545
2019 Q3	$352M	Buy	1,981,238 +93,165	+5%	+$20.1M	0.03%	532
2019 Q2	$492M	Buy	1,888,073 +25,908	+1%	+$6.87M	0.04%	444
2019 Q1	$532M	Buy	1,862,165 +96,928	+5%	+$32.2M	0.04%	408
2018 Q4	$574M	Buy	1,765,237 +33,333	+2%	+$11.6M	0.05%	342
2018 Q3	$779M	Buy	1,731,904 +197,962	+13%	+$78M	0.06%	304
2018 Q2	$627M	Buy	1,533,942 +436,108	+40%	+$158M	0.05%	353
2018 Q1	$319M	Sell	1,097,834 -23,795	-2%	-$6.03M	0.03%	538
2017 Q4	$210M	Buy	1,121,629 +20,047	+2%	+$3.74M	0.02%	676
2017 Q3	$186M	Buy	1,101,582 +30,391	+3%	+$4.6M	0.02%	685
2017 Q2	$154M	Buy	1,071,191 +23,933	+2%	+$3.22M	0.01%	750
2017 Q1	$131M	Buy	1,047,258 +20,221	+2%	+$2.34M	0.01%	812
2016 Q4	$116M	Sell	1,027,037 -71,401	-7%	-$8.27M	0.01%	841
2016 Q3	$141M	Buy	1,098,438 +15,596	+1%	+$1.87M	0.01%	727
2016 Q2	$118M	Sell	1,082,842 -233,326	-18%	-$23.2M	0.01%	767
2016 Q1	$125M	Buy	1,316,168 +474,209	+56%	+$40M	0.01%	762
2015 Q4	$76M	Buy	841,959 +13,131	+2%	+$1.11M	0.01%	955
2015 Q3	$76.9M	Buy	828,828 +66,189	+9%	+$5.83M	0.01%	937
2015 Q2	$50.1M	Buy	762,639 +14,798	+2%	+$983K	0.01%	1266
2015 Q1	$53.5M	Buy	747,841 +15,294	+2%	+$830K	0.01%	1196
2014 Q4	$27.9M	Buy	732,547 +4,883	+0.7%	+$154K	﹤0.01%	1554
2014 Q3	$18.1M	Sell	727,664 -7,805	-1%	-$198K	﹤0.01%	1816
2014 Q2	$18.5M	Sell	735,469 -10,424	-1%	-$243K	﹤0.01%	1859
2014 Q1	$19.4M	Buy	745,893 +15,859	+2%	+$439K	﹤0.01%	1806
2013 Q4	$19.5M	Buy	730,034 +7,603	+1%	+$188K	﹤0.01%	1773
2013 Q3	$13.8M	Buy	722,431 +39,652	+6%	+$906K	﹤0.01%	1939
2013 Q2	$14.7M	Buy	+682,779	New	+$13.7M	﹤0.01%	1821

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

State Street's ABMD Position: Q4 2022 in Review

State Street sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,071,180 shares — an estimated $509M sold.

State Street first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $779M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

State Street reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
State Street sold 2,071,180 Abiomed Inc shares in Q4 2022, an estimated $509M.
State Street first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
State Street's Abiomed Inc position peaked at $779M in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.